BioLife Solutions, Inc. (BLFS)

BioLife Solutions Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	137.3	143.27	161.76	119.16	48.09	27.37
Revenue Growth (YoY)	-15.89%	-11.43%	35.75%	147.79%	75.69%	38.64%
Cost of Revenue	92.02	96.52	107.94	82.11	20.65	8.76
Gross Profit	45.27	46.75	53.82	37.05	27.44	18.61
Selling, General & Admin	77	80.31	69.24	47.67	21.69	13.59
Research & Development	18.18	18.8	14.8	11.82	6.72	3.17
Other Operating Expenses	20.36	20.67	120.08	9.84	3.7	2.02
Operating Expenses	115.53	119.77	204.12	69.33	32.11	18.78
Operating Income	-70.26	-73.02	-150.3	-32.29	-4.67	-0.17
Interest Expense / Income	1.61	1.81	0.69	0.49	-0.04	-0.5
Other Expense / Income	-9.14	-8.57	-6.16	-3.74	-3.18	3.53
Pretax Income	-62.73	-66.26	-144.83	-29.03	-1.44	-3.2
Income Tax	0.21	0.17	-5.02	-20.12	-3.26	-1.54
Net Income	-62.93	-66.43	-139.81	-8.91	1.82	-1.66
Shares Outstanding (Basic)	45	44	42	39	27	19
Shares Outstanding (Diluted)	45	44	42	39	27	19
Shares Change	5.59%	2.91%	10.33%	41.01%	40.32%	19.71%
EPS (Basic)	-1.42	-1.52	-3.29	-0.23	0.07	-0.09
EPS (Diluted)	-1.42	-1.52	-3.29	-0.23	-0.06	-0.09
Free Cash Flow	-22.02	-23.74	-22.41	-19.34	-0.77	-1.12
Free Cash Flow Per Share	-0.48	-0.54	-0.53	-0.50	-0.03	-0.06
Gross Margin	32.97%	32.63%	33.27%	31.09%	57.07%	68.00%
Operating Margin	-51.17%	-50.96%	-92.91%	-27.09%	-9.70%	-0.62%
Profit Margin	-45.84%	-46.36%	-86.43%	-7.48%	3.79%	-6.05%
Free Cash Flow Margin	-16.04%	-16.57%	-13.85%	-16.23%	-1.59%	-4.08%
EBITDA	-49.74	-51.75	-124.18	-13.62	4.32	-1.39
EBITDA Margin	-36.23%	-36.12%	-76.77%	-11.43%	8.99%	-5.08%
Depreciation & Amortization	11.38	12.7	19.96	14.92	5.81	2.31
EBIT	-61.12	-64.45	-144.14	-28.54	-1.48	-3.7
EBIT Margin	-44.51%	-44.98%	-89.11%	-23.95%	-3.08%	-13.51%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).